Definitions:
Diuretic: |
Agent that increases urine volume. |
Natriuretic: |
Agent that increases in renal sodium excretion. |
Aquaretics: |
Agent that causes an increase in excretion of solute-free water (Osmotic Diuretics) |
Diuretic Agents:
Carbonic anhydrase inhibitors: |
Acetazolamide |
Loop Diuretics: |
Frusemide, ethacrynic acid, torsemide, bumetanide |
Thiazide Diuretics: |
Hydrochlorothiazide, chlorthiazide, indapamide |
Potassium sparing Diuretics: |
Spironolactone, eplerenone, amiloride, triamterene |
Osmotic Diuretics: |
Mannitol |
ADH antagonists: |
Conivaptan |
Carbonic Anhydrase Inhibitors:
> Bicarbonate diresis (sodium bicarbonate excretion)
> Metabolic acidosis
>Increased potassium loss ( High sodium concentration reaching collecting duct.)
> Diuresis limited to 2-3 days
> Uses: - severe acute glaucoma
- High altitude sickness
> A/E: renal stones
|
|
Loop Diuretics:
> Inhibit cotransport of Na+, K+ and Cl-
> 'High' ceiling' diuretics
> Adverse effects: - Hypokalemia
- Alkalosis
- Ototoxicity
> Clinical Use: = Oedema -> Heart failure, ascites, pulmonary oedema.
= Short duration of action (4hrs) -> not preferred in HTN
Thiazide Diuretics:
> Inhibit sodium chloride cotransport
> Moderate, sustained Na+and Cl- diuresis
> Adverse effects: - Hypokalemia, metabolic alkalosis, hypercalcemia
- Hyperglycemia, hyperuricemia, elevated lipids.
> Clinical Uses: = Hypertension
|
|
Potassium-sparing Diuretics:
> Aldosterone antagonitsts: - Spironolactose
- Eplerenone
-> Reduces synthesis of sodium channels
> Sodium channel inhibitors: - Amiloride
- Triamterene
-> Decreased sodium reabsorption
> Adverse Effects: - Hyperkalemia, - Acidosis, - Gynecomastia
> Indications: HTN and HF
> Should never be used with angiotensin antogonists
ADH Antagonists:
> Antidiuretic hormone facilitates water reabsorption (in collecting tubule)
> ADH stimulates V2 receptors: Stimulation of adenylyl cyclase
-> Increased cAMP = causes insertion of water channels (aquaporins) in the luminal membrane.
> ADH antagonists: Decrease water absorption by blocking V2 receptors (Convaptan, Tolvaptan)
> Uses: syndrome of inappropriate ADH secretion.
|
Created By
Metadata
Comments
No comments yet. Add yours below!
Add a Comment
Related Cheat Sheets
More Cheat Sheets by Carmilaa